Oxidation	0	9	O
in	10	12	O
rheumatoid	13	23	O
arthritis	24	33	O
.	33	34	O

Oxygen	36	42	B-Drug_or_compound
metabolism	43	53	O
has	54	57	O
an	58	60	O
important	61	70	O
role	71	75	O
in	76	78	O
the	79	82	O
pathogenesis	83	95	O
of	96	98	O
rheumatoid	99	109	O
arthritis	110	119	O
.	119	120	O

Reactive	121	129	B-Drug_or_compound
oxygen	130	136	I-Drug_or_compound
species	137	144	I-Drug_or_compound
(	145	146	O
ROS	146	149	B-Drug_or_compound
)	149	150	O
produced	151	159	O
in	160	162	O
the	163	166	O
course	167	173	O
of	174	176	O
cellular	177	185	O
oxidative	186	195	O
phosphorylation	196	211	O
,	211	212	O
and	213	216	O
by	217	219	O
activated	220	229	O
phagocytic	230	240	B-Cell
cells	241	246	I-Cell
during	247	253	O
oxidative	254	263	O
bursts	264	270	O
,	270	271	O
exceed	272	278	O
the	279	282	O
physiological	283	296	O
buffering	297	306	O
capacity	307	315	O
and	316	319	O
result	320	326	O
in	327	329	O
oxidative	330	339	O
stress	340	346	O
.	346	347	O

The	348	351	O
excessive	352	361	O
production	362	372	O
of	373	375	O
ROS	376	379	B-Drug_or_compound
can	380	383	O
damage	384	390	O
protein	391	398	O
,	398	399	O
lipids	400	406	B-Drug_or_compound
,	406	407	O
nucleic	408	415	B-Drug_or_compound
acids	416	421	I-Drug_or_compound
,	421	422	O
and	423	426	O
matrix	427	433	B-Cellular_component
components	434	444	I-Cellular_component
.	444	445	O

They	446	450	O
also	451	455	O
serve	456	461	O
as	462	464	O
important	465	474	O
intracellular	475	488	O
signaling	489	498	O
molecules	499	508	O
that	509	513	O
amplify	514	521	O
the	522	525	O
synovial	526	534	B-Multi-tissue_structure
inflammatory	535	547	O
-	547	548	O
proliferative	548	561	O
response	562	570	O
.	570	571	O

Repetitive	572	582	O
cycles	583	589	O
of	590	592	O
hypoxia	593	600	O
and	601	604	O
reoxygenation	605	618	O
associated	619	629	O
with	630	634	O
changes	635	642	O
in	643	645	O
synovial	646	654	B-Multi-tissue_structure
perfusion	655	664	O
are	665	668	O
postulated	669	679	O
to	680	682	O
activate	683	691	O
hypoxia	692	699	B-Gene_or_gene_product
-	699	700	I-Gene_or_gene_product
inducible	700	709	I-Gene_or_gene_product
factor	710	716	I-Gene_or_gene_product
-	716	717	I-Gene_or_gene_product
1alpha	717	723	I-Gene_or_gene_product
and	724	727	O
nuclear	728	735	B-Gene_or_gene_product
factor	736	742	I-Gene_or_gene_product
-	742	743	I-Gene_or_gene_product
kappaB	743	749	I-Gene_or_gene_product
,	749	750	O
two	751	754	O
key	755	758	O
transcription	759	772	O
factors	773	780	O
that	781	785	O
are	786	789	O
regulated	790	799	O
by	800	802	O
changes	803	810	O
in	811	813	O
cellular	814	822	O
oxygenation	823	834	O
and	835	838	O
cytokine	839	847	O
stimulation	848	859	O
,	859	860	O
and	861	864	O
that	865	869	O
in	870	872	O
turn	873	877	O
orchestrate	878	889	O
the	890	893	O
expression	894	904	O
of	905	907	O
a	908	909	O
spectrum	910	918	O
of	919	921	O
genes	922	927	O
critical	928	936	O
to	937	939	O
the	940	943	O
persistence	944	955	O
of	956	958	O
synovitis	959	968	O
.	968	969	O

An	970	972	O
understanding	973	986	O
of	987	989	O
the	990	993	O
complex	994	1001	O
interactions	1002	1014	O
involved	1015	1023	O
in	1024	1026	O
these	1027	1032	O
pathways	1033	1041	O
might	1042	1047	O
allow	1048	1053	O
the	1054	1057	O
development	1058	1069	O
of	1070	1072	O
novel	1073	1078	O
therapeutic	1079	1090	O
strategies	1091	1101	O
for	1102	1105	O
rheumatoid	1106	1116	O
arthritis	1117	1126	O
.	1126	1127	O

